151 related articles for article (PubMed ID: 30028222)
21. pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity.
Xu S; Wusiman A; Liu Z; Gu P; Ni H; Zhang Y; Hu Y; Liu J; Wu Y; Wang D
Int J Biol Macromol; 2019 Mar; 125():865-875. PubMed ID: 30576729
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of melanoma metastasis by dual-peptide PLGA NPS.
Arruda DC; de Oliveira TD; Cursino PHF; Maia VSC; Berzaghi R; Travassos LR; Tada DB
Biopolymers; 2017 Sep; 108(5):. PubMed ID: 28547860
[TBL] [Abstract][Full Text] [Related]
24. Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.
Smith SJ; Rahman CV; Clarke PA; Ritchie AA; Gould TW; Ward JH; Shakesheff KM; Grundy RG; Rahman R
Ann R Coll Surg Engl; 2014 Oct; 96(7):495-501. PubMed ID: 25245726
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel Delivery to the Brain for Glioblastoma Treatment.
AbdEl-Haq M; Kumar A; Ait Mohand FE; Kravchenko-Balasha N; Rottenberg Y; Domb AJ
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511480
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
27. Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation.
Ananta JS; Paulmurugan R; Massoud TF
Neurol Res; 2016 Jan; 38(1):51-9. PubMed ID: 26905383
[TBL] [Abstract][Full Text] [Related]
28. Baclofen-Loaded Poly (D,L-Lactide-Co-Glycolic Acid) Nanoparticles for Neuropathic Pain Management:
Nigam K; Kaur A; Tyagi A; Manda K; Gabrani R; Dang S
Rejuvenation Res; 2019 Jun; 22(3):235-245. PubMed ID: 30175946
[TBL] [Abstract][Full Text] [Related]
29. Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents.
Musumeci T; Serapide MF; Pellitteri R; Dalpiaz A; Ferraro L; Dal Magro R; Bonaccorso A; Carbone C; Veiga F; Sancini G; Puglisi G
Eur J Pharm Biopharm; 2018 Dec; 133():309-320. PubMed ID: 30399400
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent magnetic PEI-PLGA nanoparticles loaded with paclitaxel for concurrent cell imaging, enhanced apoptosis and autophagy in human brain cancer.
Wang X; Yang L; Zhang H; Tian B; Li R; Hou X; Wei F
Colloids Surf B Biointerfaces; 2018 Dec; 172():708-717. PubMed ID: 30245296
[TBL] [Abstract][Full Text] [Related]
31. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.
Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y
Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046
[TBL] [Abstract][Full Text] [Related]
32. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC
Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic angiogenesis by local sustained release of microRNA-126 using poly lactic-co-glycolic acid nanoparticles in murine hindlimb ischemia.
Tsumaru S; Masumoto H; Minakata K; Izuhara M; Yamazaki K; Ikeda T; Ono K; Sakata R; Minatoya K
J Vasc Surg; 2018 Oct; 68(4):1209-1215. PubMed ID: 29242072
[TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles.
Zou L; Chen F; Bao J; Wang S; Wang L; Chen M; He C; Wang Y
Drug Deliv; 2016; 23(3):908-16. PubMed ID: 24904975
[TBL] [Abstract][Full Text] [Related]
35. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
36. Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma.
Kaffashi A; Lüle S; Bozdağ Pehlivan S; Sarısözen C; Vural İ; Koşucu H; Demir T; Buğdaycı KE; Söylemezoğlu F; Karlı Oğuz K; Mut M
J Pharm Pharmacol; 2017 Aug; 69(8):1010-1021. PubMed ID: 28471040
[TBL] [Abstract][Full Text] [Related]
37. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
38. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
39. Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
Wang H; Su W; Wang S; Wang X; Liao Z; Kang C; Han L; Chang J; Wang G; Pu P
Nanoscale; 2012 Oct; 4(20):6501-8. PubMed ID: 22961067
[TBL] [Abstract][Full Text] [Related]
40. [Effects of rapamycin-loaded poly(lactic-co-glycolic) acid nanoparticles on distribution of cell cycle, expression of p27 protein, and proliferation of human umbilical arterial vascular smooth muscle cell in vitro].
Miao LF; Huang CL; Chen LF; Zhu WL; Yang J; Wang YG; Zhang H; Liu PM; She MP; Song CX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):32-8. PubMed ID: 20236585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
